Showing results (141-150 of 205) with videos related to
Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|December 1, 1987
Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteersW Al-Nakib, P G Higgins, I Barrow, et al.Journal of Interferon Research|January 1, 1980
Skin reactions to interferon inoculations are reduced but not abolished by purificationG M Scott, W E Stewart, D A Tyrrell, et al.Epidemiology and Infection|October 1, 1987
Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV))C W Potter, R Jennings, M J Ali, et al.Journal of Medical Virology|November 1, 1986
Detection of human rhinoviruses and their molecular relationship using cDNA probesW Al-Nakib, G Stanway, M Forsyth, et al.Microvascular Research|October 22, 2005
A 2-D/3-D model-based method to quantify the complexity of microvasculature imaged by in vivo multiphoton microscopyJames A Tyrrell, Vijay Mahadevan, Ricky T Tong, et al.Clinical and Experimental Immunology|October 1, 1983
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studiesT H Bacon, A de Vere-Tyndall, D A Tyrrell, et al.The Journal of Hygiene|September 1, 1972
Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus VaccinesD S Freestone, S Hamilton-Smith, G C Schild, et al.Investigative Ophthalmology & Visual Science|March 20, 2012
Even moderate visual impairments degrade drivers' ability to see pedestrians at nightJoanne M Wood, Richard A Tyrrell, Alex Chaparro, et al.Vaccine|January 1, 1993
Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteersC R Pringle, A H Filipiuk, B S Robinson, et al.Antiviral Research|August 1, 1983
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2R J Phillpotts, G M Scott, P G Higgins, et al.Pageof 21